• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    98.60 Up 1.51(1.56%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 64,538   48,973   31,388  
    Cost of Revenue9,136  5,732  3,601  
    Gross Profit 55,402   43,241   27,787  
    Operating Expenses
    Research Development12,122  9,274  10,790  
    Selling General and Administrative22,570  17,984  15,782  
    Non Recurring1,084  1,040  1,022  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 19,626   14,943   193  
    Income from Continuing Operations
    Total Other Income/Expenses Net(3,464)(3,660)(1,134)
    Earnings Before Interest And Taxes16,162  11,283  (941)
    Interest Expense4,860  2,077  2,924  
    Income Before Tax11,302  9,206  (3,865)
    Income Tax Expense410  374  (1,191)
    Minority Interest1,132   -   -  
    Net Income From Continuing Ops12,024  8,832  (2,674)
    Non-recurring Events
    Discontinued Operations -  2,588  2,147  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 12,024   11,420   (527)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 12,024   11,420   (527)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.